Archive for November 2021
FDA Clears SeptiCyte® RAPID – The First One-Hour, Direct-from-Blood Sepsis Test
Fully automated diagnostic tool SeptiCyte® RAPID quantifies the relative expression levels of genes involved in a patient’s immune response to infection to aid in a diagnosis in one hour for patients suspected of sepsis Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has received…
Read More